The short answer
Rescheduling would move cannabis from Schedule I to Schedule III of the Controlled Substances Act. That one change does not legalize cannabis. It does three things that matter: it recognizes accepted medical use, it lowers federal trafficking penalties, and it removes the tax rule known as 280E that forces state-licensed cannabis businesses to pay federal tax on gross income instead of net profit. If you buy at a dispensary, your day at the counter barely changes. If you own the dispensary, the math changes a lot.
What changes if cannabis lands on Schedule III
- Taxes. IRC 280E blocks deductions for businesses trafficking in Schedule I or II substances. Schedule III escapes that rule. A retailer that pays tax on gross receipts could start deducting payroll, rent, and inventory like a normal business. This is the biggest money item on the list, and it explains why cannabis stocks jump every time rescheduling news breaks.
- Federal recognition of medical value. Schedule III requires a currently accepted medical use in treatment in the United States. Placement there is the government saying, in formal terms, that cannabis has medical value. That reverses the Schedule I position.
- Lower federal criminal exposure. Trafficking penalties under the CSA scale with schedule. Moving down a schedule lowers statutory maximums and the quantity thresholds that trigger mandatory minimums. Simple possession penalties shift less than most people assume.
- Research. Schedule I registration adds layers: a separate DEA registration, strict security rules, and a small federally approved supply of flower. Schedule III researchers still register, but the process is lighter and materials are easier to get.
- Banking and insurance. Schedule III does not rewrite the Bank Secrecy Act. It does lower the risk score financial institutions assign to cannabis accounts, and banks that stayed away because of Schedule I could reconsider. Nothing is promised here. It depends on the institution and on Treasury guidance.
What rescheduling does not do
- It does not legalize adult use. Possessing a Schedule III drug without a valid prescription is still a federal crime. Recreational sales in your state stay legal only under state law.
- It does not turn dispensaries into pharmacies. Schedule III drugs are dispensed by prescription. A state-licensed dispensary is not a pharmacy, and a budtender is not a pharmacist. That mismatch is unresolved, and it is the strongest argument critics raise.
- It does not open interstate commerce. State lines still matter. Moving product across a border without federal authorization is still trafficking.
- It does not change state law or clear records. Expungement, possession limits, and medical card programs are state questions.
- It does not settle employment or immigration rules. Employers can still test and fire under many state and federal frameworks, and immigration consequences flow from federal law that a schedule shift does not erase.
- It does not happen on its own. Rescheduling runs through formal rulemaking: notice, public comment, an administrative hearing, and a final order from the DEA Administrator. Courts can review the result.
Why the process keeps stalling
HHS finished its scientific review in 2023 and recommended Schedule III. DEA then issued a proposed rule to move cannabis and held hearings that stretched from late 2024 into 2025. The administrative law judge who presided over those hearings recommended against the change, which is a recommendation rather than a decision. The DEA Administrator has final say, and the rule could also shift through executive action or litigation. So the honest answer to "is it rescheduled yet" is no, not as of this writing, and the timeline is uncertain.
cannabis rescheduling dea hearing update
What it means for you
If you buy in a legal state, expect the label on the jar to stay the same. Prices might drift down over time if growers and retailers get real deductions and pass along some of the savings, but nothing in rescheduling forces a price cut. The visible changes land on the industry side: cleaner books, easier capital, more clinical research, and a slow shift in how banks and landlords treat cannabis tenants.
is marijuana becoming legal federally
The piece I would watch is the prescription question. If cannabis becomes a Schedule III drug, the FDA drug approval framework comes with it. Congress could pass a law to carve out state-legal programs, or the two systems could sit in conflict for years. That fight, not the schedule number, decides what a dispensary looks like in five years.